Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
4
×
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
life sciences
medicare
4
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
4
×
startups
4
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
biogen
bristol-myers squibb
cancer immunotherapy
clinical trials
deals
drug prices
abbvie
aduro biotech
What
bio
roundup
drug
alzheimer’s
companies
pharmaceutical
price
prices
annual
appetite
approval
assessed
attention
biogen’s
biopharmaceutical
biotech
black
bread
butter
buyout
cancer
cash
communities
conference
convo
diabetes
diamond’s
different
drugs
earlier
eli
esmo
europe
fail
failures
gene
germany
giant
grabbed
hasn’t
Language
Current search:
medicare
×
startups
×
" seattle top stories "
×
cancer
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More